valu usd unless otherwis note
increment ep headwind long-
view deliv solid print recent result give us
confid manag stabil underli busi
fx termin bone cement agreement
bonesupport increment headwind chang
confid long-term turnaround stori begin
deliv top/bottom-lin beat exclud fx fuel strong
perform hip benefit tender announc
revenu fce y/i rbce hip
standout quarter y/i addit intern
tender capit placement set benefit top-line
estim world-wide recon market grew
y/i constant currenc vs albeit easier y/
comp lost world-wide recon market share
larg similar give us confid stabil
recon busi
manag ahead schedul rosa robot total knee
believ north campu remedi remain track
first five rosa robot total knee case done singl day
australian surgeon ahead intern timelin
schedul initi soft launch robot follow
full commerci launch expect aggress
system price flexibl altern purchas strategi
believ suppli constraint recent fda warn
letter impact abil deliv commit
lower sale ep estim reflect fx
termin bone cement suppli agreement reduc
revenu estim y/i guidanc
ep estim declin guidanc separ
lower revenu estim y/i
ep estim declin y/i
manag estim fx loss bone cement revenu result
increment ep headwind partial
off-set lower tax rate interest expens
continu believ new leadership unlock valu
share patienc need believ result indic
manag stabil underli busi
path market growth y/i sooner continu
recommend long-term investor expect bryan hanson
turn around compani howev patienc need
remedi issu still process fix manag
reinvest busi drive top-line growth new knee
shoulder robot product ramp throughout
price prior trade day market close estimate unless otherwis note
believ share outperform
peer group follow key reason
believ world-wide recon market larg stabl
given recent commentari orthoped manag
team well surgeon check believ
world-wide recon market larg stabl fact
world-wide recon market growth remain stabl
y/i rang everi year
expect stabl world-wide recon trend continu
 job outlook overal economi
continu slowli improv price pressur remain
constant y/i rang includ mix
recent acquisit upcom new product launch
focus fill portfolio gap acceler top-line
growth addit ldrh expand zbh mi portfolio
add fastest-grow cervic disc market
share put compani within strike distanc
separ acquisit med-tech
sa provid robot play orthoped
market final note sever import
new/upcom product launch acceler
cementless knee persona revis system stemless
new leadership unlock valu share
patienc need expect manag begin
long-term investor expect bryan hanson
turn around compani howev patienc need
remedi issu still process
fix new manag reinvest busi
drive top-line growth new knee shoulder
expect manag begin focus portfolio
manag increas weight averag
bloomberg capit market estim upside/downside/target
base case scenario price target assum
compani grow top line line market growth rate
medium term assum fda
issu warn letter north campu
base case scenario appli multipl peer
pro-forma adjust dilut cash ep estim
scenario model long-term adjust
cash ep growth slightli peer high-single-digit y/
rang analysi support outperform rate
upsid scenario assum return
top-line growth suppli concern resolv
compani regain surgeon confid launch new
product scenario also assum compani new ceo
bring addit experienc medic devic manag
help lead compani also explor potenti
divestitur sever under-perform busi includ
dental scenario long-term adjust dilut
ep growth could slightli larg cap md
downsid scenario assum compani
grow top-line well market growth rate
owe continu recon share loss on-going pressur
dental bone heal spine busi final call
pure price world-wide recon market take anoth
step scenario long-term adjust cash
ep growth would mid-single-digit y/i
deriv price target appli multipl pro-forma adjust
dilut cash ep estim large-cap med-tech peer believ
discount multipl appropri given lower top-lin growth rel
peer uncertainti regard on-going manufacturing/suppli issu price target
support outperform rate
risk rate price target
impedi achiev price target rate includ company-specif risk
suspens delay launch new product normal industri risk includ
competit depend agent distributor currenc intellectu properti
reimburs slow compani end market clinic trial risk regulatori
inc design develop manufactur market reconstruct
orthopaed implant includ small/larg joint dental spinal implant trauma
product sport medicin product relat orthopaed surgic product
sport extrem trauma
interest expens net
stock compens net tax
net incom attribut zmh
sport extrem trauma
